Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 30
MDL Plaintiffs Say Pfizer Can't Bar Depositions of Sales Reps
N.J. Judge Orders Merck to Disclose Expenses from Joint Vioxx Trial
BYU, Professor Say Pfizer Misappropriated Profits, Credit for Celebrex
Parties Dispute Physicians' Joinder in Federal Vioxx Lawsuits
Plaintiff in First Calif. Vioxx Trial States Intention to Seek Retrial
MDL Judge Says Experts' Tutorial Statements Not Impeachment Evidence
Merck Seeks to Shield 'Martin Report' from Plaintiffs' Discovery Requests
Arthritis Drugs - Issue: 29
Vioxx Plaintiffs Say Merck Not Prejudiced, Dismissal Unwarranted
